{"DataElement":{"publicId":"6551907","version":"1","preferredName":"Protocol Deviation Occurrence Code","preferredDefinition":"Information related to the occurrence of a protocol deviation._A variation from processes or procedures defined in a protocol. Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety, and are often acknowledged and accepted in advance by the sponsor. (CDISC Glossary)_A symbol or combination of symbols which is assigned to the members of a collection.","longName":"PROTO_DEV_CD","context":"CITN","contextVersion":"1","DataElementConcept":{"publicId":"2434996","version":"1","preferredName":"Protocol Deviation Occurrence","preferredDefinition":"Information related to the occurrence of a protocol deviation.","longName":"PROT_DEV_OCURS","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2434994","version":"1","preferredName":"Protocol Deviation","preferredDefinition":"An unintended departure from the study plan which has not been prospectively reviewed and approved by the IRB and FDA.","longName":"C50996","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol Deviation","conceptCode":"C50996","definition":"A variation from processes or procedures defined in a protocol. Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety, and are often acknowledged and accepted in advance by the sponsor. (CDISC Glossary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06F49B98-85BB-323D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-12-06","modifiedBy":"ONEDATA","dateModified":"2005-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06F49B98-85BC-323D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6551899","version":"1","preferredName":"CITN Protocol Deviation Code","preferredDefinition":"A variation from processes or procedures defined in a protocol. Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety, and are often acknowledged and accepted in advance by the sponsor. (CDISC Glossary)_A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6551899v1.0","context":"CITN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"12","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-7586-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"11","valueDescription":"Treatment Administration","ValueMeaning":{"publicId":"5808688","version":"1","preferredName":"Treatment Administration","longName":"5808688","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4ECE5226-06AF-182C-E053-F662850A4384","latestVersionIndicator":"Yes","beginDate":"2017-05-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-759D-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"10","valueDescription":"Institutional Review Board Reporting","ValueMeaning":{"publicId":"6551900","version":"1","preferredName":"Institutional Review Board Reporting","longName":"6551900","preferredDefinition":"A specially constituted independent review body comprised of medical, scientific and non-scientific members established and designated by an entity to ensure the protection of the rights, safety and well-being of human subjects recruited to participate in biomedical or behavioral research according to the requirements outlined in Title 38, part 16 (same as Title 45, part 46 and Title 21, part 56) of the U.S. Code of Federal Regulations. IRB responsibility include but not limited to the reviewing, approving, and providing continuing review of trial protocol and amendments and of the methods and material(s) to be used in obtaining and documenting informed consent of the trial. Other equivalent committees with the same or similar functions are also considered to be IRBs.: The act of providing a short account.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Institutional Review Board","conceptCode":"C16741","definition":"A specially constituted independent review body comprised of medical, scientific and non-scientific members established and designated by an entity to ensure the protection of the rights, safety and well-being of human subjects recruited to participate in biomedical or behavioral research according to the requirements outlined in Title 38, part 16 (same as Title 45, part 46 and Title 21, part 56) of the U.S. Code of Federal Regulations. IRB responsibility include but not limited to the reviewing, approving, and providing continuing review of trial protocol and amendments and of the methods and material(s) to be used in obtaining and documenting informed consent of the trial. Other equivalent committees with the same or similar functions are also considered to be IRBs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reporting","conceptCode":"C25651","definition":"The act of providing a short account.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-75AA-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-75C5-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"9","valueDescription":"Concomitant Agent","ValueMeaning":{"publicId":"2744968","version":"1","preferredName":"Concomitant Agent","longName":"2744968","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BB3A0D5-BF6D-3B82-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-75DB-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"8","valueDescription":"Withdraw Criterion","ValueMeaning":{"publicId":"6551901","version":"1","preferredName":"Withdraw Criterion","longName":"6551901","preferredDefinition":"To cease active participation in; remove from active use.: That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Withdraw","conceptCode":"C38061","definition":"To cease active participation in; remove from active use.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-75E9-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-7604-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"7","valueDescription":"Recruitment Procedure","ValueMeaning":{"publicId":"6551902","version":"1","preferredName":"Recruitment Procedure","longName":"6551902","preferredDefinition":"The process of enrolling, enlisting, or adding individuals to a group.: Any stepwise set of actions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recruitment","conceptCode":"C78343","definition":"The process of enrolling, enlisting, or adding individuals to a group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Procedure","conceptCode":"C79751","definition":"Any stepwise set of actions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-7611-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-762A-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"6","valueDescription":"Patient Visit Schedule Window","ValueMeaning":{"publicId":"6551903","version":"1","preferredName":"Patient Visit Schedule Window","longName":"6551903","preferredDefinition":"A visit by a patient or study participant to a medical professional.: An ordered list of times at which things are planned to occur.: A time period, or other type of interval, during which something may be achieved, obtained or observed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Visit","conceptCode":"C39564","definition":"A visit by a patient or study participant to a medical professional.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Schedule","conceptCode":"C25211","definition":"An ordered list of times at which things are planned to occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Window","conceptCode":"C48921","definition":"A time period, or other type of interval, during which something may be achieved, obtained or observed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-7638-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-7653-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"5","valueDescription":"Drug Accountability Domain","ValueMeaning":{"publicId":"2659969","version":"1","preferredName":"Drug Accountability Domain","longName":"2659969","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to drug accountability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Product Accountability Domain","conceptCode":"C49578","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to drug and other product accountability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BEA2A0-D8A6-6CE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-7669-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"4","valueDescription":"Procedure Laboratory Test Result","ValueMeaning":{"publicId":"6551904","version":"1","preferredName":"Procedure Laboratory Test Result","longName":"6551904","preferredDefinition":"Any stepwise set of actions.: The outcome of a laboratory test.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Procedure","conceptCode":"C79751","definition":"Any stepwise set of actions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Test Result","conceptCode":"C36292","definition":"The outcome of a laboratory test.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-7677-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-7692-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"3","valueDescription":"Inclusion Criteria Exclusion Criteria","ValueMeaning":{"publicId":"6551905","version":"1","preferredName":"Inclusion Criteria Exclusion Criteria","longName":"6551905","preferredDefinition":"Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.: Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inclusion Criteria","conceptCode":"C25532","definition":"Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-769F-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-76B8-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"2","valueDescription":"Adverse Event Serious Adverse Event","ValueMeaning":{"publicId":"6551906","version":"1","preferredName":"Adverse Event Serious Adverse Event","longName":"6551906","preferredDefinition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).: Any expected or unexpected adverse event, related or unrelated to the intervention, occurring at any agent dose, any phase of product or procedure testing, that results in any of the following outcomes: death, a life-threatening adverse event, requires inpatient hospitalization (not required as part of the treatment) or prolongation of existing hospitalization, a persistent or significant disability or incapacity, or cancer, or a congenital anomaly or birth defect. Important medical events that may not result in the listed outcomes may be considered as serious when, based upon appropriate medical judgment, they represent significant hazards or potentially serious harm to the research subject or others and may require medical intervention to prevent one of the outcomes listed in this definition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Serious Adverse Event","conceptCode":"C41335","definition":"Any expected or unexpected adverse event, related or unrelated to the intervention, occurring at any agent dose, any phase of product or procedure testing, that results in any of the following outcomes: death, a life-threatening adverse event, requires inpatient hospitalization (not required as part of the treatment) or prolongation of existing hospitalization, a persistent or significant disability or incapacity, or cancer, or a congenital anomaly or birth defect. Important medical events that may not result in the listed outcomes may be considered as serious when, based upon appropriate medical judgment, they represent significant hazards or potentially serious harm to the research subject or others and may require medical intervention to prevent one of the outcomes listed in this definition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-76C5-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-76E0-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"},{"value":"1","valueDescription":"Consent","ValueMeaning":{"publicId":"3288352","version":"1","preferredName":"Consent","longName":"3288352","preferredDefinition":"Permission to do something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Consent","conceptCode":"C25460","definition":"Permission to do something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE7C66E1-38A8-2078-E040-BB89AD4312AA","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A1A1CDA-76F4-055D-E053-F662850A4846","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6551898","version":"1","preferredName":"Protocol Deviation Code","preferredDefinition":"A variation from processes or procedures defined in a protocol. Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety, and are often acknowledged and accepted in advance by the sponsor. (CDISC Glossary):A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C50996:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol Deviation","conceptCode":"C50996","definition":"A variation from processes or procedures defined in a protocol. Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety, and are often acknowledged and accepted in advance by the sponsor. (CDISC Glossary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-7554-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"ONEDATA","dateModified":"2018-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CITN CRF: Cancer Immunotherapy Trials Network Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A1A1CDA-7565-055D-E053-F662850A4846","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"KNABLEJ","dateModified":"2018-11-15","changeDescription":"11/15/18 jk released per Vivy. 11/7/18 jk CITN coded protocol deviation value list.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Data Element Protocol Deviation Occurrence Code does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Protocol Deviation Occurrence Code does not have Preferred Question Text","url":null,"context":"CITN"}],"origin":"CITN CRF: Cancer Immunotherapy Trials Network Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A17661E-E87A-552A-E053-F662850A6F6F","latestVersionIndicator":"Yes","beginDate":"2018-11-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-11-07","modifiedBy":"KNABLEJ","dateModified":"2018-11-15","changeDescription":"11/15/18 jk released per Vivy.  11/7/18 jk created for CITN specific PD code set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}